[Skip to content]

.

Pioneering treatment helps dangerous birthmark

13 January 2012
Millie and parents

There has been widespread coverage in the media this week about Great Ormond Street Hospital (GOSH) patient Millie Field.

Millie was offered a pioneering drug treatment at the hospital, which dramatically reduced the size of a potentially lethal birthmark which was restricting her breathing.

The drug Millie was given was Propranolol, which had been shown to successfully treat the condition in a clinical trial in France.

Doctors at the hospital had previously diagnosed Millie with a haemangioma, a birthmark caused by a benign tumour of the blood vessels in the skin.

Jane Linward, clinical nurse specialist for Dermatology at GOSH said: “We are delighted to see Millie is doing so well.” 

Contact information

GOSH-ICH Press Office: 020 7239 3125
For genuine and urgent out of hours call speak to switchboard on 020 7405 9200.

Notes to editors

Great Ormond Street Hospital for Children NHS Trust is the country’s leading centre for treating sick children, with the widest range of specialists under one roof.

With the UCL Institute of Child Health, we are the largest centre for paediatric research outside the US and play a key role in training children’s health specialists for the future.

Our charity needs to raise £50 million every year to help rebuild and refurbish Great Ormond Street Hospital, buy vital equipment and fund pioneering research. With your help we provide world class care to our very ill children and their families.

Recent press releases